SetPoint Medical provides a device-based therapy for rheumatoid arthritis.
SetPoint Medical has raised $115.0M in total funding. The most recent round was Series D. The last funding was announced in August 2025.
SetPoint Medical's investors include Norwest Venture Partners, New Enterprise Associates, Catalio Capital Management, Boston Scientific, Ally Bridge Group.
SetPoint Medical is headquartered in Valencia, United States.
SetPoint Medical provides a device-based therapy for rheumatoid arthritis.
SetPoint Medical is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SetPoint Medical — Funding & Investors." VCBacked, August 11, 2025, https://www.vcbacked.co/company/setpoint-medical. Accessed July 19, 2026.
VCBacked. (2025). SetPoint Medical — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/setpoint-medical
{{cite web |title=SetPoint Medical — Funding & Investors |url=https://www.vcbacked.co/company/setpoint-medical |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated